Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TWi Pharmaceuticals Inc.

www.twipharma.com

Latest From TWi Pharmaceuticals Inc.

Allergan Shifts Restasis Patents To Native American Tribe To Invoke Immunity From IPR

The tribe will move to get IPR proceedings dismissed, but the strategy isn't expected to affect ANDA litigation. Allergan's CEO said the company could use a similar approach with other patents and notes that other companies may follow.

Intellectual Property Legal Issues

Allergan Shifts Restasis Patents To Native American Tribe To Invoke Immunity From IPR

The tribe will move to get IPR proceedings dismissed, but the strategy isn't expected to affect ANDA litigation. Allergan's CEO said the company could use a similar approach with other patents and notes that other companies may follow.

Legal Issues Intellectual Property

Chinese Biotechs Lining Up For Cross-Straits IPOs In Taiwan

Thanks to surging valuations, a relaxed profitability rule and a familiar business culture, Taiwan offers allure to mainland biotechs aspiring to raise funds across the strait.

BioPharmaceutical China

Deals Shaping The Medical Industry, October 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Dermatology
  • Gastrointestinal
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Taiwan
  • Parent & Subsidiaries
  • TWi Pharmaceuticals Inc.
  • Senior Management
  • Chih-Ming Chen, Interim Pres. & CEO
    Eva Ho, SVP, Fin. & CFO
    Jian-bo Xie, EVP, R&D
  • Contact Info
  • TWi Pharmaceuticals Inc.
    Phone: 2 2657 3350
    4F, No. 41, Lane 221
    Gangqian Rd.
    Taipei City, 11494
    Taiwan
UsernamePublicRestriction

Register